Caspases in Myocardial Infarction

Advances in Clinical Chemistry

Volumn 44, Issue , 2007, Pages 1-33

  Zidar, Nina ^a   Jera, Jeruc ^a   Maja, Jerše ^a   Dušan, Štajer ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ENZYME INHIBITOR;

ANIMAL; APOPTOSIS; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW;

ANIMALS; APOPTOSIS; CASPASES; ENZYME INHIBITORS; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; REPERFUSION INJURY;

EID: 34347251872     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(07)44001-X     Document Type: Review

References (187)

1. Kostin S., Pool L., Elsasser A., Hein S., Drexler H., Arnon E., et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92 (2003) 715-724
2. Kostin S. Pathways of myocyte death: Implications for development of clinical laboratory biomarkers. Adv Clin Chem 40 (2005) 37-98
3. Reeve J., Duffy A., O'Brien T., and Samali A. Don't lose heart-therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. J Cell Mol Med 9 (2005) 609-622
4. Majno G., and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146 (1995) 3-15
5. Levin S., Bucci T., Cohen S., Fix A., Hardisty J., LeGrand E., et al. The nomenclature of cell death: Recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol Pathol 27 (1999) 484-490
6. Wyllie A., Kerr J., and Currie A. Cell death: The significance of apoptosis. Int Rev Cytol 68 (1980) 251-306
7. Canman C., Tang H., Normolle D., Lawrence T., and Maybaum J. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: Implications for mechanisms of resistance and cytotoxicity. Proc Natl Acad Sci USA 89 (1992) 10474-10478
8. Brown D., Sun X., and Cohen G. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 268 (1993) 3037-3039
9. Wyllie A. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 (1980) 555-556
10. Kaufmann S. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res 49 (1989) 5870-5878
11. Ucker D., Obermiller P., Eckhart W., Apgar J., Berger N., and Myers J. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol 12 (1992) 3060-3069
12. Lazebnik Y., Cole S., Cooke C., Nelson W., and Earnshaw W. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 123 (1993) 7-22
13. Homburg C., de Haas M., von dem Borne A., Verhoeven A., Reutelingsperger C., and Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85 (1995) 532-540
14. Savill J. Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 53 (1997) 491-508
15. Klionsky D., and Emr S. Autophagy as a regulated pathway of cellular degradation. Science 290 (2000) 1717-1721
16. Zimmermann K., Bonzon C., and Green D. The machinery of programmed cell death. Pharmacol Ther 92 (2001) 57-70
17. James T. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90 (1994) 556-573
18. Takemura G., and Fujiwara H. Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10 (2006) 56-75
19. Chandrashekhar Y., and Narula J. Death hath a thousand doors to let out life. Circ Res 92 (2003) 710-714
20. Takemura G., and Fujiwara H. Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther 104 (2004) 1-16
21. Chandrashekhar Y. Role of apoptosis in ventricular remodeling. Curr Heart Fail Rep 2 (2005) 18-22
22. Nicotera P., Leist M., and Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 102-103 (1998) 139-142
23. Shiraishi J., Tatsumi T., Keira N., Akashi K., Mano A., Yamanaka S., et al. Important role of energy-dependent mitochondrial pathways in cultured rat cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 281 (2001) H1637-H1647
24. Martin S., and Green D. Protease activation during apoptosis: Death by a thousand cuts?. Cell 82 (1995) 349-352
25. Denault J., and Salvesen G. Caspases: Keys in the ignition of cell death. Chem Rev 102 (2002) 4489-4500
26. Lavrik I., Golks A., and Krammer P. Caspases: Pharmacological manipulation of cell death. J Clin Invest 115 (2005) 2665-2672
27. Boatright K., Renatus M., Scott F., Sperandio S., Shin H., Pedersen I., et al. A unified model for apical caspase activation. Mol Cell 11 (2003) 529-541
28. Martinon F., and Tschopp J. Inflammatory caspases: Linking as intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004) 561-574
29. Weber C., and Vincenz C. The death domain superfamily: A tale of two interfaces?. Trends Biochem Sci 26 (2001) 475-481
30. Lahm A., Paradisi A., Green D., and Melino G. Death fold domain interaction in apoptosis. Cell Death Differ 10 (2003) 10-12
31. Kroemer G., and Reed J. Mitochondrial control of cell death. Nat Med 6 (2000) 513-519
32. Danial N., and Korsmeyer S. Cell death: Critical control points. Cell 116 (2004) 205-219
33. Hill M., Adrain C., and Martin S. Portrait of a killer: The mitochondrial apoptosome emerges from the shadows. Mol Interv 3 (2003) 19-26
34. Jiang X., and Wang X. Cytochrome c-mediated apoposis. Annu Rev Biochem 73 (2004) 87-106
35. Green D. Apoptotic pathways: Ten minutes to dead. Cell 121 (2005) 671-674
36. Crow M., Mani K., Nam Y., and Kitsis R. The mitochondrial death pathway and cardiac apoptosis. Circ Res 95 (2004) 957-970
37. Adams J., Sakata Y., Davis M., Sah V., Wang Y., Liggett S., et al. Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95 (1998) 10140-10145
38. Kong J., and Rabkin S. Mitochondrial effects with ceramide-induced cardiac apoptosis are different from those of palmitate. Arch Biochem Biophys 412 (2003) 196-206
39. Chipuk J., Kuwana T., Bouchier-Hayes L., Droin N., Newmeyer D., Schuler M., et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (2004) 1010-1014
40. Date T., Mochizuki S., Belanger A., Yamakawa M., Luo Z., Vincent K., et al. Differential effects of membrane and soluble Fas ligand on cardiomyocytes: Role in ischemia/reperfusion injury. J Mol Cell Cardiol 35 (2003) 811-821
41. Bialik S., Cryns V., Drincic A., Miyata S., Wollowick A., Srinivasan A., et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res 85 (1999) 403-414
42. Narula J., Pandey P., Arbustini E., Haider N., Narula N., Kolodgie F., et al. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 96 (1999) 8144-8149
43. Scheubel R., Bartling B., Simm A., Silber R., Drogaris K., Darmer D., et al. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: Fragile balance of myocyte survival?. J Am Coll Cardiol 39 (2002) 481-488
44. Czerski L., and Nuñez G. Apoptosome formation and caspase activation: Is it different in the heart?. J Mol Cell Cardiol 37 (2004) 643-652
45. de Moissac D., Gurevich R., Zheng H., Singal P., and Kirshenbaum L. Caspase activation and mitochondrial cytochrome c release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 32 (2000) 53-63
46. Lundberg K., and Szweda L. Initiation of mitochondrial-mediated apoptosis during cardiac reperfusion. Arch Biochem Biophys 432 (2004) 50-57
47. Yamaguchi S., Yamaoka M., Okuyama M., Nitoube J., Fukui A., Shirakabe M., et al. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol 83 (1999) 1500-1503
48. Schumann H., Morawietz H., Hakim K., Zerkowski H., Eschenhagen T., Holtz J., et al. Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium. Biochem Biophys Res Commun 239 (1997) 794-798
49. Jeremias I., Kupatt C., Martin-Villalba A., Habazettl H., Schenkel J., Boekstegers P., et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 102 (2000) 915-920
50. Lee P., Sata M., Lefer D., Factor S., Walsh K., and Kitsis R. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 284 (2003) H456-H463
51. Gomez L., Chavanis N., Argaud L., Chalabreysse L., Gateau-Roesch O., Ninet J., et al. Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 289 (2005) H2153-H2158
52. Scarabelli T., Stephanou A., Rayment N., Pasini E., Comini L., Curello S., et al. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104 (2001) 253-256
53. Stephanou A., Brar B., Liao Z., Scarabelli T., Knight R., and Latchman D. Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury. Cell Death Differ 8 (2001) 434-435
54. Scarabelli T., Stephanou A., Pasini E., Comini L., Raddino R., Knight R., et al. Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res 90 (2002) 745-748
55. Zheng T., and Flavell R. Divinations and surprises: Genetic analysis of caspase function in mice. Exp Cell Res 256 (2000) 67-73
56. Abraham M., and Shaham S. Death without caspases, caspases without death. Trends Cell Biol 14 (2004) 184-193
57. Kuida K., Lippke J., Ku G., Harding M., Livingston D., Su M., et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267 (1995) 2000-2003
58. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80 (1995) 401-411
59. Fantuzzi G., Puren A., Harding M., Livingston D., and Dinarello C. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta-converting enzyme (caspase-1)-deficient mice. Blood 91 (1998) 2118-2125
60. Bergeron L., Perez G., Macdonald G., Shi L., Sun Y., Jurisicova A., et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12 (1998) 1304-1314
61. Kuida K., Zheng T., Na S., Kuan C., Yang D., Karasuyama H., et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384 (1996) 368-372
62. Woo M., Hakem R., Soengas M., Duncan G., Shahinian A., Kagi D., et al. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12 (1998) 806-819
63. Fernando P., Kelly J., Balazsi K., Slack R., and Megeney L. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 99 (2002) 11025-11030
64. Zheng T., Hunot S., Kuida K., and Flavell R. Caspase knockouts: Matters of life and death. Cell Death Differ 6 (1999) 1043-1053
65. Varfolomeev E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J., Mett I., et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9 (1998) 267-276
66. Sakamaki K., Inoue T., Asano M., Sudo K., Kazama H., Sakagami J., et al. Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ 9 (2002) 1196-1206
67. Kuida K., Haydar T., Kuan C., Gu Y., Taya C., Karasuyama H., et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase-9. Cell 94 (1998) 325-337
68. Hakem R., Hakem A., Duncan G., Henderson J., Woo M., Soengas M., et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94 (1998) 339-352
69. Wang J., Miura M., Jung Y., Zhu H., Li E., and Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92 (1998) 501-509
70. Hisahara S., Yuan J., Momoi T., Okano H., and Miura M. Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 193 (2001) 111-122
71. Kang S., Wang S., Hara H., Peterson E., Namura S., Amin-Hanjani S., et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 149 (2000) 613-622
72. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
73. Wang J., and Lenardo M. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 113 (2000) 753-757
74. Earnshaw W., Martins L., and Kaufmann S. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68 (1999) 383-424
75. Fischer U., Jänicke R., and Schulze-Osthoff K. Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ 10 (2003) 76-100
76. Rao L., Perez D., and White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135 (1996) 1441-1455
77. Liu X., Li P., Widlak P., Zou H., Luo X., Garrard W., et al. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 95 (1998) 8461-8466
78. Ling Y., Zhong Y., and Perez-Soler R. Disruption of cell adhesion and caspase-mediated proteolysis of beta- and gamma-catenins and APC protein in paclitaxel-induced apoptosis. Mol Pharmacol 59 (2001) 593-603
79. Weiske J., Schöneberg T., Schröder W., Hatzfeld M., Tauber R., and Huber O. The fate of desmosomal proteins in apoptotic cells. J Biol Chem 276 (2001) 41175-41181
80. Nicotera P., and Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 23 (2004) 2757-2765
81. Faubel S., and Edelstein C. Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 5 (2005) 269-287
82. Köhler C., Orrenius S., and Zhivotovsky B. Evaluation of caspase activity in apoptotic cells. J Immunol Methods 265 (2002) 97-110
83. Gorman A., Hirt U., Zhivotovsky B., Orrenius S., and Ceccatelli S. Application of a fluorometric assay to detect caspase activity in thymus tissue undergoing apoptosis in vivo. J Immunol Methods 226 (1999) 43-48
84. Srinivasan A., Roth K., Sayers R., Shindler K., Wong A., Fritz L., et al. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 5 (1998) 1004-1016
85. Gown A., and Willingham M. Improved detection of apoptotic cells in archival paraffin sections: Immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 50 (2002) 449-454
86. Duan W., Garner D., Williams S., Funckes-Shippy C., Spath I., and Blomme E. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199 (2003) 221-228
87. de Boer R., van Veldhuisen D., van der Wijk J., Brouwer R., de Jonge N., Cole G., et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail 6 (2000) 330-337
88. Yang F., Sun X., Beech W., Teter B., Wu S., Sigel J., et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am J Pathol 152 (1998) 379-389
89. Suurmeijer A., van der Wijk J., van Veldhuisen D., Yang F., and Cole G. Fractin immunostaining for the detection of apoptotic cells and apoptotic bodies in formalin-fixed and paraffin-embedded tissue. Lab Invest 79 (1999) 619-620
90. Freude B., Masters T., Robicsek F., Fokin A., Kostin S., Zimmermann R., et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32 (2000) 197-208
91. Compton M., and Cidlowsky J. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 118 (1986) 38-45
92. Facchinetti A., Tessarollo L., Mazzocchi M., Kingston R., Collavo D., and Biasi G. An improved method for the detection of DNA fragmentation. J Immunol Methods 136 (1991) 125-131
93. Gavrieli Y., Sherman Y., and Ben-Sasson S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119 (1992) 493-501
94. Ansari B., Coates P., Greenstein B., and Hall P. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170 (1993) 1-8
95. Wijsman J., Jonker R., Keijzer R., van de Velde C., Cornelisse C., and van Dierendonck J. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41 (1993) 7-12
96. Yasuda M., Umemura S., Osamura R., Kenjo T., and Tsutsumi Y. Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method. Arch Histol Cytol 58 (1995) 185-190
97. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., and Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 21 (1995) 1465-1468
98. Kockx M., Muhring J., Knaapen M., and de Meyer G. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 152 (1998) 885-888
99. Ohno M., Takemura G., Ohno A., Misao J., Hayakawa Y., Minatoguchi S., et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 98 (1998) 1422-1430
100. Kanoh M., Takemura G., Misao J., Hayakawa Y., Aoyama T., Nishigaki K., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 99 (1999) 2757-2764
101. Knaapen M., Davies M., De Bie M., Haven A., Martinet W., and Kockx M. Apoptotic versus autophagic cell death in hearth failure. Cardiovasc Res 51 (2001) 304-312
102. Koda M., Takemura G., Kanoh M., Hayakawa K., Kawase Y., Maruyama R., et al. Myocites positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: A manifestation of cardiac hypertrophy rather than failure. J Pathol 199 (2003) 229-236
103. Tateyama H., Tada T., Hattori H., Murase T., Li W., and Eimoto T. Effects of prefixation and fixation times on apoptosis detection by in situ end-labeling of fragmented DNA. Arch Pathol Lab Med 122 (1998) 252-255
104. Gál I., Varga T., Szilágyi I., Balázs M., Schlammadinger J., and Szábo G. Protease-elicited TUNEL positivity of non-apoptotic fixed cells. J Histochem Cytochem 48 (2000) 963-969
105. Haunstetter A., and Izumo S. Toward antiapoptosis as a new treatment modality. Circ Res 86 (2000) 371-376
106. Tsutsumi Y., and Kamoshida S. Pitfalls and caveats in histochemically demonstrating apoptosis. Acta Histochem Cytochem 36 (2003) 271-280
107. Gottlieb R., Burleson K., Kloner R., Babior B., and Engler R. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94 (1994) 1621-1628
108. Fliss H., and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79 (1996) 949-956
109. Kang P., Haunstetter A., Aoki H., Usheva A., and Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 87 (2000) 118-125
110. Zhao Z., Nakamura M., Wang N., Wilcox J., Shearer S., Ronson R., et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45 (2000) 651-660
111. Itoh G., Tamura J., Suzuki M., Suzuki Y., Ikeda H., Koike M., et al. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146 (1995) 1325-1331
112. Bardales R., Hailey L., Xie S., Schaefer R., and Hsu S. In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 149 (1996) 821-829
113. Olivetti G., Quaini F., Sala R., Lagrasta C., Corradi D., Bonacina E., et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28 (1996) 2005-2016
114. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., and Voipio-Pulkki L. Apoptosis in human acute myocardial infarction. Circulation 95 (1997) 320-323
115. Veinot J., Gattinger D., and Fliss H. Early apoptosis in human myocardial infarcts. Hum Pathol 28 (1997) 485-492
116. James T. Normal and abnormal consequences of apoptosis in the human heart. Annu Rev Physiol 60 (1998) 309-325
117. Toyoda Y., Shida T., Wakita N., Ozaki N., Takahashi R., and Okada M. Evidence of apoptosis induced by myocardial ischemia: A case of ventricular septal rupture following acute myocardial infarction. Cardiology 90 (1998) 149-151
118. Piro F., di Gioia C., Gallo P., Giordano C., and d'Amati G. Is apoptosis a diagnostic marker of acute myocardial infarction?. Arch Pathol Lab Med 124 (2000) 827-831
119. Rodriguez-Calvo M., Tourret M., Concheiro L., Munoz J., and Suarez-Penaranda J. Detection of apoptosis in ischemic heart. Usefulness in the diagnosis of early myocardial injury. Am J Forensic Med Pathol 22 (2001) 278-284
120. Abbate A., Bussani R., Biondi-Zoccai G., Rossiello R., Silvestri F., Baldi F., et al. Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at post-mortem examination in humans late after an acute myocardial infarction. Circulation 106 (2002) 1051-1054
121. Edston E., Gröntoft L., and Johnsson J. TUNEL: A useful screening method in sudden cardiac death. Int J Legal Med 116 (2002) 22-26
122. Nakatome M., Matoba R., Ogura Y., Tun Z., Iwasa M., Maeno Y., et al. Detection of cardiomyocyte apoptosis in forensic autopsy cases. Int J Legal Med 116 (2002) 17-21
123. Zidar N., Dolenc-Stražar Z., Jeruc J., and Štajer D. Immunohistochemical expression of activated caspase-3 in human myocardial infarction. Virchows Archiv 448 (2006) 75-79
124. Hofstra L., Liem I., Dumont E., Boersma H., van Heerde W., Doevendans P., et al. Visualisation of cell death in vivo in patients with acute myocardial infaction. Lancet 356 (2000) 209-212
125. Fadok V., Savill J., Haslett C., Bratton D., Doherty D., Campbell P., et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149 (1992) 4029-4035
126. Elsässer A., Suzuki K., and Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 32 (2000) 711-724
127. Brancolini C., Lazarevic D., Rodriguez J., and Schneider C. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin. J Cell Biol 139 (2001) 759-771
128. James T., Terasaki F., Pavlovich E., and Vikhert A. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med 122 (1993) 309-323
129. Narula J., Haider N., Virmani R., DiSalvo T., Kolodgie F., Hajjar R., et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 335 (1996) 1182-1189
130. Valente M., Calabrese F., Thiene G., Angelini A., Basso C., Nava A., et al. In vivo evidence of apoptosis in arrhytmogenic right ventricular cardiomyopathy. Am J Pathol 152 (1998) 479-484
131. Beranek J. Further evidence of cardiomyocyte apoptosis in humoral (microvascular) rejection of human cardiac allografts. J Heart Lung Transplant 23 (2004) 378-379
132. Sharov V., Sabbah H., Shimoyama H., Goussev A., Lesch M., and Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148 (1996) 141-149
133. Elsässer A., Schlepper M., Klovekorn W., Cai W., Zimmermann R., Muller K., et al. Hibernating myocardium: An incomplete adaptation to ischemia. Circulation 96 (1997) 2920-2931
134. Maruyama R., Takemura G., Aoyama T., Hayakawa K., Koda M., Kawase Y., et al. Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: Beating and rate are associated with the apoptotic process. Am J Pathol 159 (2001) 863-891
135. Takemura G., Kato S., Aoyama T., Hayakawa Y., Kanoh M., Maruyama R., et al. Characterization of ultrastructure and its relation with DNA fragmentation in Fas-induced apoptosis of cultured cardiac myocytes. J Pathol 193 (2001) 546-556
136. Baldi A., Abbate A., Bussani R., Patti G., Melfi R., Angelini A., et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34 (2002) 165-174
137. Abbate A., Biondi-Zoccai G., Bussani R., Dobrina A., Camilot D., Feroce F., et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J Am Coll Cardiol 41 (2003) 753-760
138. Biondi-Zoccai G., Abbate A., Vasaturo F., Scarpa S., Santini D., Leone A., et al. Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease. Int J Cardiol 94 (2004) 105-110
139. Sam F., Sawyer D., Chang D., Eberli F., Ngoy S., Jain M., et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279 (2000) H422-H428
140. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 280 (2001) H2726-H2731
141. Schwarz K., Simonis G., Yu X., Wiedemann S., and Strasser R. Apoptosis at a distance: Remote activation of caspase-3 occurs early after myocardial infarction. Mol Cell Biochem 281 (2006) 45-54
142. Pfeffer M., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
143. Anversa P., Olivetti G., and Capasso J. Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 68 (1991) 7D-16D
144. Beltrami C., Finato N., Rocco M., Feruglio G., Puricelli C., Cigola E., et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89 (1994) 151-163
145. Oskarsson H., Coppey L., Weiss R., and Li W. Antioxidants attenuate myocyte apoptosis in the remote non-infarcted myocardium following large myocardial infarction. Cardiovasc Res 45 (2000) 679-687
146. Palmen M., Daemen M., Bronsaer R., Dassen W., Zandbergen H., Kockx M., et al. Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice. Cardiovasc Res 50 (2001) 516-524
147. Communal C., Sumandea M., de Tombe P., Narula J., Solaro R., and Hajjar R. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 99 (2002) 6252-6256
148. Narula J., Haider N., Virmani R., DiSalvo T., Kolodgie F., Hajjar R., et al. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 335 (1996) 1182-1189
149. Kanoh M., Takemura G., Misao J., Hayakawa Y., Aoyama T., Nishigaki K., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 99 (1999) 2757-2764
150. Laugwitz K., Moretti A., Weig H., Gillitzer A., Pinkernell K., Ott T., et al. Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 12 (2001) 2051-2063
151. Moretti A., Weig H., Ott T., Seyfarth M., Holthoff H., Grewe D., et al. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci USA 99 (2002) 11860-11865
152. Hayakawa K., Takemura G., Kanoh M., Li Y., Koda M., Kawase Y., et al. Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage. Circulation 108 (2003) 104-109
153. Yarbrough W., Mukherjee R., Escobar G., Sample J., McLean J., Dowdy K., et al. Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: A potentially novel pathway. J Thorac Cardiovasc Surg 126 (2003) 1892-1899
154. Chandrashekhar Y., Sen S., Anway R., Shuros A., and Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-1 cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J Am Coll Cardiol 43 (2004) 295-301
155. Takemura G., Ohno M., Hayakawa Y., Misao J., Kanoh M., Ohno A., et al. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after acute myocardial infarction. Circ Res 82 (1998) 1130-1138
156. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction. Cardiovasc Res 45 (2000) 630-641
157. Jugdutt B., and Idikio H. Apoptosis and oncosis in acute coronary syndromes: Assessment and implications. Mol Cell Biochem 270 (2005) 177-200
158. Knowlton K., and Chien K. Inflammatory pathways and cardiac repair: The affliction of infarction. Nat Med 5 (1999) 1122-1123
159. Hansen P. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91 (1995) 1872-1885
160. Zidar N., Jeruc J., Balažic J., and Štajer D. Neutrophils in human myocardial infarction with rupture of the free wall. Cardiovasc Pathol 14 (2005) 247-250
161. Squadrito F., Altavilla D., Squadrito G., Saitta A., Deodato B., Arlotta M., et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury. J Mol Cell Cardiol 32 (2000) 429-440
162. Heymans S., Luttun A., Nuyens D., Theilmeier G., Creemers E., Moons L., et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5 (1999) 1135-1142
163. Webb P., Wang K., Scheel-Toellner D., Pongracz J., Salmon M., and Lord J. Regulation of neutrophil apoptosis: A role for protein kinase C and phosphatidylinositol-3-kinase. Apoptosis 5 (2000) 451-458
164. Grigg J., Savill J., Sarraf C., Haslett C., and Silverman M. Neutrophil apoptosis and clearance from neonatal lung. Lancet 338 (1991) 720-722
165. Cox G., Crossley J., and Xing Z. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol 12 (1995) 232-237
166. Renshaw S., Parmar J., Singleton V., Rowe S., Dockrell D., Dower S., et al. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 170 (2003) 1027-1033
167. Desmoulière A., Redard M., Darby I., and Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar formation. Am J Pathol 146 (1995) 56-66
168. Fischer U., and Schulze-Osthoff K. New approaches and therapeutic targeting apoptosis in disease. Pharmacol Rev 57 (2005) 187-215
169. Ekert P., Silke J., and Vaux D. Caspase inhibitors. Cell Death Differ 6 (1999) 1081-1086
170. Chandrashekhar Y., and Sen S. Gene therapy and pharmaceutical modulation of apoptosis. Cardiol Clin 19 (2001) 173-190
171. Reed J. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 7 (2001) 314-319
172. Garg S., Narula J., and Chandrashekhar Y. Apoptosis and heart failure: Clinical relevance and therapeutic target. J Mol Cell Cardiol 38 (2005) 73-79
173. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97 (1998) 276-281
174. Holly T., Drincic A., Byun Y., Nakamura S., Harris K., Klocke F., et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 31 (1999) 1709-1715
175. Huang J., Radinovic S., Rezaiefar P., and Black S. In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia. Eur J Pharmacol 402 (2000) 139-142
176. Mocanu M., Baxter G., and Yellon D. Caspase inhibition and limitation of myocardial infarct size: Protection against lethal reperfusion injury. Br J Pharmacol 130 (2000) 197-200
177. Okamura T., Miura T., Takemura G., Fujiwara H., Iwamoto H., Kawamura S., et al. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 45 (2000) 642-650
178. Kovacs P., Bak I., Szendrei L., Vecsernyes M., Varga E., Blasig I., et al. Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts. Naunyn Schmiedebergs Arch Pharmacol 364 (2001) 501-507
179. Li H., Karwatowska-Prokopczuk E., Mutomba M., Wu J., Karanewsky D., Valentino K., et al. Pharmacology of caspase inhibitors in rabbit cardiomyocytes subjected to metabolic inhibition and recovery. Antioxid Redox Signal 3 (2001) 113-123
180. Ruetten H., Badorff C., Ihling C., Zeiher A., and Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J Am Coll Cardiol 38 (2001) 2063-2070
181. Chapman J., Magee W., Stukenbrok H., Beckius G., Milici A., and Tracey W. A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. Eur J Pharmacol 456 (2002) 59-68
182. Balsam L., Kofidis T., and Robbins R. Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction. J Surg Res 124 (2005) 194-200
183. Saitoh T., Nakajima T., Takahashi T., and Kawahara K. Changes in cardiovascular function on treatment of inhibitors of apoptotic signal transduction pathway in left ventricular remodeling after myocardial infarction. Cardiovasc Pathol 15 (2006) 130-138
184. Hotchkiss R., Chang K., Swanson P., Tinsley K., Hui J., Klender P., et al. Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte. Nat Immunol 1 (2000) 496-501
185. O'Brien T., and Lee D. Prospects for caspase inhibitors. Mini Rev Med Chem 4 (2004) 153-165
186. Gill C., Mestril R., and Samali A. Losing heart: The role of apoptosis in heart disease-a novel therapeutic target?. FASEB J 16 (2002) 135-146
187. Morissette M., and Rosenzweig A. Targeting survival signaling in heart failure. Curr Opin Pharmacol 5 (2005) 165-170